Malignant mixed mesodermal tumor of the ovary treated with a cisplatin-irinotecan combination: case report

Eur J Gynaecol Oncol. 2001;22(5):319-21.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives
  • Cisplatin / administration & dosage
  • Enzyme Inhibitors / administration & dosage
  • Female
  • Humans
  • Irinotecan
  • Middle Aged
  • Mixed Tumor, Mesodermal / drug therapy*
  • Ovarian Neoplasms / drug therapy*
  • Remission Induction
  • Topoisomerase I Inhibitors

Substances

  • Enzyme Inhibitors
  • Topoisomerase I Inhibitors
  • Irinotecan
  • Cisplatin
  • Camptothecin